Program
Tolvaptan
Also written as “OPC-41061”, “tolvaptan” and “Tolvaptan MR”.
Its studies are mostly in Polycystic Kidney, Autosomal Dominant · Hyponatremia · Heart Failure · Fibrosis · Kidney Failure, Chronic, led by 2 companies.
Drug pageTolvaptan: every studyAll 89 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Otsuka | 541 open or running | phase 4since Sep 15, 2011 | Aug 13, 2002 | Dec 28, 2028phase 3 · NCT04782258 |
| Jiangsu HengRui Medicineits history only | 10 open or running | phase 3since Jan 5, 2012 | Jan 5, 2012 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Otsuka only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 37 studies since Aug 13, 2002.
- Dec 9, 2013Phase 2 study in Inappropriate ADH SyndromeNCT02009878 · 30 enrolled · Czech Republic, Denmark, Germany and more
- Dec 11, 20132 phase 3 studies in HyponatremiaNCT02012959, NCT02020278
- Jun 6, 2014Phase 3 study in Renal Insufficiency, ChronicNCT02160145 · 1,370 enrolled · United States, Argentina, Australia and more
- Sep 25, 2014Phase 3 study in Polycystic Kidney, Autosomal DominantNCT02251275 · 1,803 enrolled · United States, Argentina, Australia and more
- Dec 23, 2014Phase 2 study in Kidney Failure, ChronicNCT02331680 · 124 enrolled · Japan
- May 8, 20152 phase 3 studies in HyponatremiaNCT02442674, NCT02449044
- Sep 15, 2016Phase 3 study in Polycystic Kidney, Autosomal DominantNCT02964273 · 91 enrolled · Belgium, Germany, Italy and more
- Dec 13, 2016Phase 1 study in Healthy Adult MaleNCT02994394 · 84 enrolled · Japan
- Feb 7, 2017Phase 3 study in Inappropriate ADH SyndromeNCT03048747 · 16 enrolled · Japan
- Aug 18, 2017Phase 3 study in Heart FailureNCT03255226 · 60 enrolled · Japan
- Apr 16, 2019Phase 4 study in Polycystic Kidney, Autosomal DominantNCT03949894 · 118 enrolled · Korea, Republic of
- Feb 19, 20212 phase 3 studies in Polycystic Kidney, Autosomal RecessiveNCT04786574, NCT04782258
- Aug 22, 20252 phase 1 studiesNCT07166887, NCT07166783
- Oct 23, 2026Primary completion moved from 2028-07-31 to 2028-12-28Date moved laterphase 3 · +5 months · NCT04782258
Ahead
- Dec 28, 2028Primary completion: phase 3 study in Polycystic Kidney, Autosomal RecessiveNCT04782258
TargetBeta
“An orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia”NCIt, by rule
“Vasopressin V2 receptor antagonist”ChEMBL 37, by rule
Studies
All 54 Otsuka leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07166887Healthy Subjects | 1 | Completed | Jul 27, 2011 | 12 |
| NCT07166783Health Subjects | 1 | Completed | Jul 4, 2011 | 10 |
| NCT04786574Polycystic Kidney, Autosomal Recessive | 3 | Withdrawn | Dec 10, 2025 | 0 |
| NCT04782258Polycystic Kidney, Autosomal Recessive · United States, Belgium, Germany and more | 3 | Recruiting | Dec 28, 2028 | 20 |
| NCT03949894Polycystic Kidney, Autosomal Dominant · Korea, Republic of | 4 | Completed | May 25, 2022 | 118 |
| NCT03255226Heart Failure · Japan | 3 | Completed | Jul 11, 2021 | 60 |
| NCT03048747Inappropriate ADH Syndrome · Japan | 3 | Completed | Mar 19, 2019 | 16 |
| NCT02994394Healthy Adult Male · Japan | 1 | Completed | Feb 28, 2017 | 84 |
| NCT02964273Polycystic Kidney, Autosomal Dominant · Belgium, Germany, Italy and more | 3 | Completed | Nov 17, 2021 | 91 |
| NCT02449044Hyponatremia | 3 | Completed | Oct 2009 | 111 |
| NCT02442674Hyponatremia | 3 | Withdrawn | Jun 22, 2017 | 0 |
| NCT02331680Kidney Failure, Chronic · Japan | 2 | Completed | May 2016 | 124 |
| NCT02251275Polycystic Kidney, Autosomal Dominant · United States, Argentina, Australia and more | 3 | Completed | Nov 9, 2018 | 1,803 |
| NCT02160145Renal Insufficiency, Chronic · United States, Argentina, Australia and more | 3 | Completed | Apr 18, 2017 | 1,370 |
| NCT02020278Hyponatremia · United States, Belgium, Czechia and more | 3 | Terminated | Oct 23, 2017 | 3 |
| NCT02012959Hyponatremia · United States, Italy, United Kingdom | 3 | Terminated | Jul 24, 2017 | 9 |
| NCT02009878Inappropriate ADH Syndrome · Czech Republic, Denmark, Germany and more | 2 | Completed | Jun 2015 | 30 |
| NCT01895322Kidney Failure, Chronic · Japan | 2 | Completed | Feb 2014 | 20 |
| NCT01876381Kidney Failure, Chronic · Japan | 2 | Completed | Feb 2014 | 26 |
| NCT02352285Heart Failure With Hyponatremia · Korea, Republic of | 4 | Terminated | Jan 2017 | 58 |
| NCT01684202Carcinomatous Edema · Japan | 2 | Completed | Dec 2013 | 43 |
| NCT01651156Edema, Cardiac · China | 3 | Completed | Jul 2013 | 244 |
| NCT01618448Edema, Cardiac · Taiwan | 3 | Completed | May 2014 | 85 |
| NCT01552590Hyponatremia · Korea, Republic of | 4 | Terminated | Apr 2012 | 74 |
| NCT01451827Polycystic Kidney, Autosomal Dominant · United States | 2 | Completed | Jul 2013 | 178 |
| NCT01439009Heart Failure · Japan | 4 | Completed | Mar 2014 | 100 |
| NCT01349348Ascites · China | 3 | Completed | May 2012 | 535 |
| NCT01336972Polycystic Kidney, Autosomal Dominant · Netherlands | 2 | Completed | Nov 2011 | 29 |
| NCT01280721Autosomal Dominant Polycystic Kidney Disease (ADPKD) · Japan | 3 | Completed | Aug 2014 | 135 |
| NCT01227512Hyponatremia · United States | 3 | Terminated | May 2013 | 124 |
| NCT01214421Polycystic Kidney, Autosomal Dominant · United States, Argentina, Australia and more | 3 | Completed | Feb 29, 2016 | 1,083 |
| NCT01210560Polycystic Kidney, Autosomal Dominant · United States | 2 | Completed | Jun 2011 | 25 |
| NCT01114828Fibrosis · Japan | 3 | Completed | Oct 2011 | 40 |
| NCT01359462Liver Cirrhosis · China | 1 | Completed | Nov 2009 | 11 |
| NCT01349335Ascites · China | 2 | Completed | Jan 2010 | 180 |
| NCT01050530Fibrosis · Japan | 3 | Completed | Feb 2012 | 162 |
| NCT01048788Fibrosis · Japan | 3 | Completed | Aug 2011 | 51 |
| NCT01022424Polycystic Kidney, Autosomal Dominant · Japan | 3 | Completed | Jul 2014 | 13 |
| NCT00841568Polycystic Kidney, Autosomal Dominant · Japan | 2 | Completed | Nov 2010 | 17 |
| NCT00664014Hyponatremia · China | 2 | Completed | Feb 2010 | 241 |
| NCT00550459Hyponatremia · United States | 3 | Completed | Feb 2009 | 57 |
| NCT00544869Edema, Cardiac · Japan | 3 | Completed | Feb 2009 | 52 |
| NCT00525265Edema, Cardiac · Japan | 3 | Completed | Jan 2009 | 20 |
| NCT00479336Fibrosis · Japan | 2 | Completed | Jan 2009 | 104 |
| NCT00462670Edema, Cardiac · Japan | 3 | Completed | Oct 2008 | 110 |
| NCT00428948Polycystic Kidney, Autosomal Dominant · United States, Argentina, Australia and more | 3 | Completed | Jan 2012 | 1,445 |
| NCT00413777Polycystic Kidney, Autosomal Dominant · United States | 2 | Completed | Jun 2010 | 46 |
| NCT00234104Heart Failure · Japan | 2 | Completed | Jan 2006 | 122 |
| NCT00201994Hyponatremia · Germany | 3 | Completed | Jul 1, 2005 | 243 |
| NCT00132886Heart Failure · United States, Romania | 2 | Completed | Dec 2006 | 140 |
| NCT00072683Hyponatremia · United States | 3 | Completed | Dec 1, 2005 | 205 |
| NCT00071331Heart Failure · United States, Argentina, Belgium and more | 3 | Completed | Jul 2006 | 3,600 |
| NCT00043771Heart Failure · United States | 2 | Completed | 40 | |
| NCT00043758Heart Failure · United States, Canada | 2 | Completed | 170 |
How it is read
Names in the registry
- “Tolvaptan”, 30 entries
- “OPC-41061”, 12 entries
- “tolvaptan”, 6 entries
- “Tolvaptan MR”, 5 entries
- “OPC-41061(Tolvaptan)”, 3 entries
Conditions, from the studies’ own filings
- Polycystic Kidney, Autosomal Dominant, 12 studies
- Hyponatremia, 11 studies
- Heart Failure, 8 studies
- Fibrosis, 4 studies
- Kidney Failure, Chronic, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.